ATE499121T1 - Viskoelastische lösungen mit natriumhyaluronat und hydroxypropylmethylcellulose, herstellung und verwendungen - Google Patents

Viskoelastische lösungen mit natriumhyaluronat und hydroxypropylmethylcellulose, herstellung und verwendungen

Info

Publication number
ATE499121T1
ATE499121T1 AT05818937T AT05818937T ATE499121T1 AT E499121 T1 ATE499121 T1 AT E499121T1 AT 05818937 T AT05818937 T AT 05818937T AT 05818937 T AT05818937 T AT 05818937T AT E499121 T1 ATE499121 T1 AT E499121T1
Authority
AT
Austria
Prior art keywords
sodium hyaluronate
preparation
hydroxypropylmethyl cellulose
viscoelastic solutions
implants
Prior art date
Application number
AT05818937T
Other languages
English (en)
Inventor
Pierre Lebreton
Original Assignee
Corneal Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corneal Innovation filed Critical Corneal Innovation
Application granted granted Critical
Publication of ATE499121T1 publication Critical patent/ATE499121T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04Macromolecular materials
    • A61L31/041Mixtures of macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043Mixtures of macromolecular materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
AT05818937T 2004-11-30 2005-11-28 Viskoelastische lösungen mit natriumhyaluronat und hydroxypropylmethylcellulose, herstellung und verwendungen ATE499121T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0412662A FR2878444B1 (fr) 2004-11-30 2004-11-30 Solutions viscoelastiques renfermant du hyaluronate de sodiu et de l'hydroxypropylmethylcellulose, preparation et utilisations
PCT/FR2005/050996 WO2006059029A2 (fr) 2004-11-30 2005-11-28 Solutions viscoelastiques renfermant du hyaluronate de sodium et de l'hydroxypropylmethyl- cellulose, preparation et utilisations

Publications (1)

Publication Number Publication Date
ATE499121T1 true ATE499121T1 (de) 2011-03-15

Family

ID=34952867

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05818937T ATE499121T1 (de) 2004-11-30 2005-11-28 Viskoelastische lösungen mit natriumhyaluronat und hydroxypropylmethylcellulose, herstellung und verwendungen

Country Status (11)

Country Link
US (1) US20080089918A1 (de)
EP (1) EP1817065B1 (de)
JP (1) JP2008521464A (de)
AT (1) ATE499121T1 (de)
CA (1) CA2589397C (de)
DE (1) DE602005026555D1 (de)
DK (1) DK1817065T3 (de)
ES (1) ES2364355T3 (de)
FR (1) FR2878444B1 (de)
PL (1) PL1817065T3 (de)
WO (1) WO2006059029A2 (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2861734B1 (fr) 2003-04-10 2006-04-14 Corneal Ind Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus
WO2008147867A2 (en) * 2007-05-23 2008-12-04 Allergan, Inc. Cross-linked collagen and uses thereof
US20120071437A1 (en) 2007-07-30 2012-03-22 Allergan, Inc. Tunable crosslinked polysaccharide compositions
US8318695B2 (en) * 2007-07-30 2012-11-27 Allergan, Inc. Tunably crosslinked polysaccharide compositions
US8697044B2 (en) 2007-10-09 2014-04-15 Allergan, Inc. Crossed-linked hyaluronic acid and collagen and uses thereof
US8114898B2 (en) 2007-11-16 2012-02-14 Allergan, Inc. Compositions and methods for treating purpura
US8394784B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having multi-stage bioactive agent delivery
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
US8394782B2 (en) * 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
AU2009288118B2 (en) 2008-09-02 2014-12-11 Allergan, Inc. Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US9114188B2 (en) 2010-01-13 2015-08-25 Allergan, Industrie, S.A.S. Stable hydrogel compositions including additives
US20110171286A1 (en) * 2010-01-13 2011-07-14 Allergan, Inc. Hyaluronic acid compositions for dermatological use
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US20110171311A1 (en) * 2010-01-13 2011-07-14 Allergan Industrie, Sas Stable hydrogel compositions including additives
US20110171310A1 (en) 2010-01-13 2011-07-14 Allergan Industrie, Sas Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use
CN102905677A (zh) 2010-03-12 2013-01-30 阿勒根工业有限公司 用于改善皮肤状况的包含透明质烷聚合物和甘露糖醇的流体组合物
ES2585388T5 (es) 2010-03-22 2019-08-08 Allergan Inc Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
US8697057B2 (en) 2010-08-19 2014-04-15 Allergan, Inc. Compositions and soft tissue replacement methods
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
CA2824483C (en) 2011-01-13 2016-08-30 Allergan, Inc. Stable hydrogels comprising cross-linked hyaluronic acid and phenylephrine
AU2012217630A1 (en) 2011-02-17 2013-09-05 Allergan, Inc. Compositions and improved soft tissue replacement methods
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
KR102312056B1 (ko) 2011-06-03 2021-10-12 알러간 인더스트리 에스에이에스 항산화제를 포함하는 피부 충전제 조성물
EP3590495A1 (de) 2011-08-25 2020-01-08 Allergan, Inc. Dermale füllstoffzusammensetzungen mit antioxidantien
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
AU2012308503B2 (en) 2011-09-14 2015-08-13 Allergan Industrie, Sas Dermal filler compositions for fine line treatment
GB201118586D0 (en) * 2011-10-27 2011-12-07 Turzi Antoine New A-PRP medical device, manufacturing machine and process
PL3175840T3 (pl) 2011-12-08 2021-01-25 Allergan Industrie, Sas Kompozycje wypełniacza skórnego
KR102062420B1 (ko) 2012-07-18 2020-01-03 알러간 인더스트리 에스에이에스 피루베이트를 함유한 히알루론산 제제
CA2886115A1 (en) 2012-10-02 2014-04-10 Allergan, Inc. Dermal filler hydrogels with vitamin a/cyclodextrin inclusion complexes
WO2014055895A1 (en) 2012-10-05 2014-04-10 Allergan, Inc. Injectable device and method for sculpting, augmenting or correcting facial features such as the chin
CN105142678A (zh) * 2012-11-02 2015-12-09 赛萨卡股份有限公司 用于眼部手术的荧光着色
EP2928426A2 (de) 2012-12-07 2015-10-14 Cesacar Participacions, S.L. Femtozellen-multishooting für die augenchirurgie
JP2017509433A (ja) 2014-04-01 2017-04-06 クロックス テクノロジーズ インコーポレイテッドKlox Technologies Inc. 組織充填剤組成物および使用方法
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
KR20170108986A (ko) 2015-01-28 2017-09-27 알레간 인코포레이티드 관절 지방 패드 제제 및 그의 사용 방법
WO2016128783A1 (en) 2015-02-09 2016-08-18 Allergan Industrie Sas Compositions and methods for improving skin appearance
PL3256179T3 (pl) 2015-02-13 2020-05-18 Allergan Industrie, Sas Implanty do kształtowania, uwydatniania lub korygowania cech twarzy takich jak broda
AU2016426150B2 (en) 2016-10-13 2022-06-30 Allergan, Inc. Coacervate hyaluronan hydrogels for dermal filler applications
CA3127191A1 (en) 2019-01-21 2020-07-30 Eclipse Medcorp, Llc Methods, systems and apparatus for separating components of a biological sample
MX2022004999A (es) 2019-10-31 2022-07-27 Eclipse Medcorp Llc Sistemas, metodos y aparatos para separar componentes de una muestra.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409904A (en) * 1984-11-13 1995-04-25 Alcon Laboratories, Inc. Hyaluronic acid compositions and methods
JPS62122671A (ja) * 1985-11-23 1987-06-03 千寿製薬株式会社 眼内手術用高粘性液の製造法
WO1995007085A1 (en) * 1993-09-07 1995-03-16 Escalon Ophthalmics, Inc. Surface active viscoelastic solutions for ocular use
AU2002360752A1 (en) * 2001-12-21 2003-07-30 Alcon, Inc. Viscoelastics for ocular surgery

Also Published As

Publication number Publication date
CA2589397C (en) 2015-03-31
ES2364355T3 (es) 2011-08-31
PL1817065T3 (pl) 2011-09-30
CA2589397A1 (en) 2006-06-08
US20080089918A1 (en) 2008-04-17
DE602005026555D1 (de) 2011-04-07
EP1817065A2 (de) 2007-08-15
DK1817065T3 (da) 2011-06-14
WO2006059029A2 (fr) 2006-06-08
FR2878444A1 (fr) 2006-06-02
WO2006059029A3 (fr) 2006-08-31
JP2008521464A (ja) 2008-06-26
FR2878444B1 (fr) 2008-04-25
EP1817065B1 (de) 2011-02-23

Similar Documents

Publication Publication Date Title
ATE499121T1 (de) Viskoelastische lösungen mit natriumhyaluronat und hydroxypropylmethylcellulose, herstellung und verwendungen
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
CY1109719T1 (el) Σκευασμα 1-[(3-υδροξυ-αδαμαντ-1-υλαμινο)-ακετυλο]-πυρρολιδινο-2-(s)-καρβονιτριλιου τροποποιημενης απελευθερωσης
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
AR018717A1 (es) COMPUESTOS DERIVADOS DE PIPERIDINA, SU USO, UN PROCESO PARA SU PREPARACIoN, COMPOSICIONES FARMACÉUTICAS QUE LOS COMPRENDEN, Y COMPUESTOS INTERMEDIARIOS.
CY1105362T1 (el) Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα
BR0210139A (pt) Composições farmacêuticas
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
SE0402762D0 (sv) Indazole sulphonamide derivatives
DK1185253T3 (da) Oralt præparat til indgivelse af en fast kombination af tramadol og diclofenac
DE60331638D1 (de) Keratin-netzwerke enthaltende wundverbände für gewebedefekte
ATE422356T1 (de) Pharmazeutische zubereitungen
ATE318607T1 (de) Heparin-haltiges ophthalmikum
NO20050664L (no) 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer
DE69828894D1 (de) Ophatlmologische zusammenssetzung
ATE485049T1 (de) Physiologisch aktive zusammensetzung gegen diabetes
NO20052505L (no) Ny bruk av dextran-sulfat
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
NO20081035L (no) Ikke-invasivt legemiddel-leveringssystem som anvender en fast sammensetning pa vevet i bakre segment av oyet
AR046672A1 (es) Prevencion y tratamiento de enfermedaes cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1,3,6(10)-trien-3,16alfa-diol
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
EA200101150A1 (ru) Раствор прукалоприда для перорального применения
NO20050903L (no) Nye piperazinyl-pyrazinonderivater for behandling av 5HT-2A reseptorrelaterte forstyrrelser
DK1411956T3 (da) Anvendelse af oversulfaterede polysaccharider som inhibitorer af HIV

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1817065

Country of ref document: EP